Tata Elxsi and Bayer Open Radiology Innovation Centre in Pune

Tata Elxsi has inaugurated the Bayer Development Centre in Radiology at its Pune facility. The centre has been set up in collaboration with Bayer, a global leader in radiology, to co-develop cutting-edge radiology devices and technology. The aim is to enhance early and accurate diagnosis of critical illnesses while ensuring patient safety and clinical efficiency.

Focus on Molecular Imaging

The new centre will initially focus on Molecular Imaging, a field critical for the detection and management of complex diseases. It will provide end-to-end engineering capabilities for advanced radiology devices, covering design, development, and validation. This integrated approach will accelerate time-to-market, improve cost efficiency, and ensure compliance with global regulatory standards.

Leveraging Tata Elxsi’s Expertise

The collaboration leverages Tata Elxsi’s deep expertise in healthcare engineering, design, and technology, along with the broader Tata and Indian innovation ecosystem. This includes access to advanced laboratories, regulatory partnerships, and highly skilled technology talent. Such an ecosystem creates a scalable foundation for innovation in the healthcare sector.

Global Reach and Impact

The centre strengthens Bayer’s ability to deliver radiology solutions across multiple geographies, including the US and EU, where demand for safe, compliant, and efficient medical technology is growing. By combining Tata Elxsi’s capabilities with Bayer’s radiology leadership, the initiative supports Bayer’s global mission of bringing innovative healthcare solutions to patients and clinicians worldwide.

Sreevatsa Sahasranaman, Sr. Vice President & Head – Healthcare & Life Sciences, Tata Elxsi, said, “This centre is more than an engineering hub—it is where Bayer’s radiology vision meets Tata Elxsi’s design, AI/ML, and regulatory expertise. Our teams will work together to translate ideas into devices that address real-world diagnostic challenges, with the assurance of safety, compliance, and global scalability.”

Tata Elxsi Share Price Performance

On September 10, 2025, Tata Elxsi share price (NSE: TATAELXSI) opened at ₹5,597.45 and closed at ₹5,843.45, up by 5.16%. The stock price touched its day’s high at ₹5,863.40 on the BSE.

Also Read: Tata Elxsi and Infineon Team Up to Drive EV Innovation in India!

Conclusion

The launch of the Bayer Development Centre in Radiology marks a significant step in advancing medical technology. This collaboration between Tata Elxsi and Bayer not only accelerates innovation in radiology but also reinforces India’s position as a hub for healthcare technology development.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.